Evidence-based recommendations for the treatment of rheumatic and immunologic diseases with calcineurin inhibitors: a consensus statement.
10.3760/cma.j.cn112138-20230416-00198
- Collective Name:National Clinical Research Center for Dematologic and Immunologic Diseases (Peking Union Medical College Hospital);Chinese Association of Rheumatology and Immunology Physicians;Chinese Research Hospital Association, Rheumatology and Immunology Professional Committee;Chinese Association of Rehabilitation Medicine, Rheumatology and Immunology Professional Committee
- Publication Type:Journal Article
- MeSH:
Humans;
Calcineurin Inhibitors/pharmacology*;
Immunosuppressive Agents/therapeutic use*;
Tacrolimus/pharmacology*;
T-Lymphocytes;
Immune System Diseases;
Rheumatic Diseases/drug therapy*
- From:
Chinese Journal of Internal Medicine
2023;62(11):1266-1281
- CountryChina
- Language:Chinese
-
Abstract:
Calcineurin inhibitors (CNI), including oral cyclosporin A and tacrolimus, are intensive immunosuppressants that are extensively used in the treatment of rheumatic and immunologic diseases in China. CNI selectively inhibit the activation and proliferation of T lymphocytes and the transcription of cytokines [such as tumor necrosis factor-α, interleukin (IL)-6, and IL-17] through inhibiting the activation of calcineurin in cells and reducing the release of IL-2. To standardize the use of CNI in the field of rheumatic and immunologic diseases, this consensus statement was developed by the National Clinical Research Center for Dermatologic and Immunologic Diseases (Peking Union Medical College Hospital), in conjunction with the Chinese Association of Rheumatology and Immunology Physicians, the Chinese Research Hospital Association, the Rheumatology and Immunology Professional Committee, and the Chinese Association of Rehabilitation Medicine. The 2011 Oxford Centre for Evidence-Based Medicine Levels of Evidence was used to rate the quality of the evidence and the strength of the recommendations, and the RIGHT (Reporting Items for practice Guidelines in HealThcare) checklist was followed to report the consensus. The consensus offers recommendations addressing nine clinical challenges to Chinese clinicians. The primary objective of this consensus is to deliver scientific and detailed guidance on CNI for Chinese clinicians, and to improve the quality of patient-centered medical services.
